Navigation Links
Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials

/p>

"EVEREST adds to the collection of data on tolvaptan and its potential uses," said Kazumichi Kobayashi, Chairman & CEO of Otsuka Pharmaceutical Development & Commercialization, Inc. "Tolvaptan, as one of our most advanced candidate therapies, exemplifies the successful application of Otsuka's expertise in new drug research and development."

About Heart Failure

More than 14 million people in Europe(6) and five million U.S. residents(7) have heart failure (HF), a serious chronic condition in which the heart cannot effectively pump blood. The direct and indirect U.S. health care expenses related to HF tally about $28 billion, ACC estimates.(5) The majority of patients hospitalized for ADHF, the worsening of chronic HF that affects 1 million US residents annually, have edema or excess body fluid.(3)

About Otsuka Pharmaceutical Development & Commercialization, Inc.

Otsuka Pharmaceutical Development and Commercialization, Inc. is involved in conducting all phases of clinical research and development of innovative healthcare products to address unmet medical needs. OPDC is well established in the scientific community as a globally focused organization that plays a leadership role in the research and development of Otsuka's ethical healthcare products. The Company is dedicated to the improvement of the quality of human life and health of patients around the world with a strong commitment to research and development in the areas of cardiovascular, neuroscience, renal and respiratory diseases, as well as cancer and ophthalmic disorders. OPDC is part of the Otsuka Pharmaceutical Group, which is comprised of 87 companies and approximately 27,000 people around the world. With 44 consolidated subsidiaries, Otsuka earned US $6.8 billion in consolidated annual revenues in fiscal 2005. For additional information, visit www.otsuka.com.

JAMA Publications:

Konstam, MA, et
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
2. Frova Phase III Study Data Demonstrates That Short-Term Prevention Treatment Reduces Frequency and Severity of Menstrual Migraine
3. New Study Results Provide Additional Data about Short- and Long-Term Use of Desvenlafaxine Succinate in the Treatment of Adults with Major Depressive Disorder
4. Anesiva Announces Phase 2 Data Showing Substantial, Long-Term Pain Reductions with Adlea(TM) (formerly 4975) in Osteoarthritis of the Knee
5. Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival
6. Surfaxin (Lucinactant) Long-Term Survival Advantage vs. Comparators Published in Pediatrics
7. Long-Term Extension of Ulcerative Colitis Study Shows Remicade Responders Maintained Improvement Through Two Years of Follow-Up
8. New Long-Term Data Analyses for Bifeprunox Show Favorable Effects Versus Placebo in Stabilized Patients with Schizophrenia
9. Medtronic Updates Long-Term ENDEAVOR I-II Clinical Data Showing Sustained Safety and Significant Reductions in Repeat Procedures
10. Taxus VI Clinical Trial Demonstrates Positive Long-Term Outcomes for Moderate-Release Paclitaxel-Eluting Stent at Four Years
11. UCB Presents Long-Term CImzia Data in Crohns Disease

Post Your Comments:
(Date:11/6/2009)...re/ -- , - Trial Will Compare NXL103 With... Multi-Resistant Staphylococcus Aureus (MRSA) Infe...ical company focused on the discovery and,developm...significant global,problem of microbial resistance...bacterial NXL103 (flopristin/linopristin), has sta...
(Date:11/5/2009)... Transcept Pharmaceutical...al company focused on the development and commerci...ortant therapeutic needs in the field of neuroscie...leconference with management to discuss third quar...2, 2009, at 5:00 p.m. Eastern Standard Time. Fina...
(Date:11/5/2009)...wswire/ -- Renee Cobos, MD, a board certified derm...t the University of California, Irvine, announced ...s results with Thermage CPT®. The updated sys...touring, features a new vibrating hand piece that ...comfort. ,, "Thermage has always been popular ...
Breaking Medicine Technology:Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 3Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI) 4Transcept Pharmaceuticals to Report Third Quarter 2009 Results and Host Conference Call on November 12 2Orange County Dermatologist Garners Outstanding Results With New Thermage CPT(R) 2NeurogesX Announces New PDUFA Date for Qutenza 28TM 29 New Drug Application 13402 1NeurogesX Announces New PDUFA Date for Qutenza 28TM 29 New Drug Application 13402 2NeurogesX Announces New PDUFA Date for Qutenza 28TM 29 New Drug Application 13402 3NeurogesX Announces New PDUFA Date for Qutenza 28TM 29 New Drug Application 13402 4Keryx Biopharmaceuticals Inc Announces Second Quarter 2009 Financial Results 13401 1Keryx Biopharmaceuticals Inc Announces Second Quarter 2009 Financial Results 13401 2Keryx Biopharmaceuticals Inc Announces Second Quarter 2009 Financial Results 13401 3Keryx Biopharmaceuticals Inc Announces Second Quarter 2009 Financial Results 13401 4Keryx Biopharmaceuticals Inc Announces Second Quarter 2009 Financial Results 13401 5Keryx Biopharmaceuticals Inc Announces Second Quarter 2009 Financial Results 13401 6Sex Hormone Protein May Predict Type 2 Diabetes 53775 1Sex Hormone Protein May Predict Type 2 Diabetes 53775 2Sex Hormone Protein May Predict Type 2 Diabetes 53775 3
...ny,(NYSE: LLY ) announced today that the U.S. Foo...lta(R) (duloxetine HCl) for the maintenance,treatm... "Relapse, the re-emergence of depressive symptom... significant clinical concern," says Doug,Williams...Eli Lilly and,Company. "This approval from the FDA...
...il,joins organizations and individuals across the ... annual World AIDS Day, December 1, 2007. Since 19...ties to raise awareness,about the HIV/AIDS pandemi...nd local efforts to stop AIDS., The 2007 and 2008...years since it was first identified, the HIV/AIDS ...
Other Medicine Technology:FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder 2FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder 3FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder 4AIDS Action Council Statement on World AIDS Day 2007: Leadership Needed for a National Strategy to Stop the AIDS Epidemic 2
(Date:11/8/2009).../ -- Speaker Nancy Pelosi and Democratic leaders h... of H.R. 3962, the Affordable Health Care for Amer... Below are the Speaker,s opening remarks: ,, ...from the President of the United States, Barack Ob...American people. I thank the President for his tre...
(Date:11/8/2009)...harmaceuticals to be available at the Company&rsqu... Toronto, ON (PRWEB) November 8, 2009 ...Biopharma Inc. today announced that the Company ha...cal grade freeze dryer and expects to make commerc... for contract manufacturing of biopharmaceuticals ...
(Date:11/8/2009)... won," said Dr. Charmaine Yoest. ,, WASHINGTON...40-194, the Stupak-Ellsworth-Pitts-Kaptur-Dahlkemp...andates and funding in HR 3962 passed on the House...sident and CEO Dr. Charmaine Yoest said, "The pass...e Americans across this country who have flooded C...
(Date:11/8/2009)...Secure the Stability of Medicare ,, HOUSTON, N...table to: J. James Rohack, M.D., President, Americ...newscom.com/cgi-bin/prnh/20081209/AMALOGO ) ,...eform bill, which will help improve the health sys...t passage of H.R. 3961 to secure the stability of ...
(Date:11/8/2009)...e Reform Bill ,, Critical legislation would s...cans ,, BALTIMORE, Nov. 7 /PRNewswire-USNewswi...of Representatives passed critical health care ref... seniors and end discrimination by insurance compa...rdable health coverage. ,, The Affordable Healt...
Breaking Medicine News(10 mins):Health News:Therapure Biopharma Inc. Announces Delivery of its First Commercial-Scale Lyophilizer 2Health News:Americans United for Life Action Comments on Passage of Pro-Life Amendment: Bipartisan Pro-life Majority Reflects the Will of the American People 2Health News:AMA Hails House Passage of Health Reform Bill (H.R. 3962) 2Health News:AARP Maryland Key Vote News Alert 2Health News:AARP Maryland Key Vote News Alert 3
...Speakers at the Congress for the International Soc...nnheim, Germany, while presenting their research p... detection of alcohol abuse and treatment is more ...es to predict the alcohol addiction while it is a...
...Researchers at the University of Jagiellonian in P...grape fruit seed reduced the size of stomach ulcer...ch ulcers and different concentration of the seed ...to have strong antibacterial and antioxidant prope...
...The Central Government of India has now issued a l...tioxidants with their corresponding reference stan...ufacture of Ayurveda, Siddha or Unani drugs. The l... The substances permitted according to the lis...
...A recent Canadian study pointed out that taking be...a glass of beer has the same health benefits as a ...ick, a lead researcher “One drink of beer or stout...a larger dose, can be harmful. The study says...
...Scientists have now cracked the genetic makeup thr...s //and Chagas disease that are caused by Trypanos.... The three diseases have mostly been to affect pe...study conducted by National Institute of Allergy a...
...The Indian government is in the process of institu... wholesale price index in order to track drug pric...sent, the government is relying on the retail audi...of formulations is not quite effective. Drug p...
Other Medicine News:Health News:Grape fruit seed extracts can heal stomach ulcers 2Health News:Three Tropical Parasites Genetic Code Unravelled 2
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
Medicine Products: